China Tumor Ablation Market Landscape Report 2022: Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 12, 2022--
The "China Tumor Ablation Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook" report has been added to ResearchAndMarkets.com's offering.
Why Buy This Report
- First-ever syndicated report with robust insights from Interventional Radiologists
- Helps in understanding the current market scenario of tumor ablation in China
- Includes 100+ slide MS PowerPoint report and a MS Excel based 5-year market forecast model
- Valuable insights from demand side of the market
- Keep up with the latest market trends and novel technologies
Identify key players, local players and emerging players in the market
- Medtronic
- Boston Scientific
- J&J ethicon
- STARmed
- Angiodynamics
- Merit Medical
- Perseon
- MedWaves
- SonaCare
- Philips
- Insightec
- Healthtronics
- Vision Medical
- Nanjing KanYou
- GreatWall
- Nanjing Fuzhong Medical Hi-Tech
- BTG/Galil
Key Topics Covered:
RESEARCH PROCESS OVERVIEW
- Detailed Research Methodology
- Desk Research and Quantitative Research
EXECUTIVE SUMMARY
TUMOR ABLATION (TA) CHINA MARKET OVERVIEW
- Market Background - What is the scope of the research?
I - HEALTHCARE INFRASTRUCTURE (PROVIDER)
- Healthcare System
- Cancer Care - By Hospital Types?
- Healthcare Structure - Challenges
II - PROCEDURE INSIGHTS
- Procedure Split by Specialist Type
- Procedure Split by Cancer Type
- Procedure Split by Modality
- Average Procedures By Physician
- Procedure Growth Rates
III - BRAND PERCEPTION
- Brand Perception (Interventionalists)
- Best-in-Class Brands
IV - COMPETITIVE INTELLIGENCE
- CI Snapshot
- Key Competitor Activities
- Product portfolio
- Product Approval Overview
- Clinical Trials Overview
- Company Profile
- Product Approvals
- Clinical Trials
- Partnerships, M&A, Collaborations
- Key Market Activities
- Major Adverse Events
V - HEALTHCARE POLICY (PAYER)
- Medical Devices Regulatory Body
- Regulatory Approval Pathway
- Reimbursement landscape
- Disease Screening and Awareness Programs
- Health Insurance Coverage
- Digital Health Policy
VI - CLINICAL INTELLIGENCE (PHYSICIAN)
- Referral Pathway
- Treatment Overview
- Treatment Care Pathway
- Treatment Guidelines
- Interventional Therapies
- Interventional Technology
- Healthcare Specialists (who are the Performing Physicians)
- Epidemiology
CONCLUSION
- FUTURE TRENDS
APPENDICES
For more information about this report visit https://www.researchandmarkets.com/r/p582tm
View source version on businesswire.com:https://www.businesswire.com/news/home/20220912005872/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: CHINA ASIA PACIFIC
INDUSTRY KEYWORD: RADIOLOGY BIOTECHNOLOGY SURGERY ONCOLOGY HEALTH MEDICAL DEVICES HOSPITALS HEALTH INSURANCE
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/12/2022 01:10 PM/DISC: 09/12/2022 01:11 PM
http://www.businesswire.com/news/home/20220912005872/en
